Cargando…
Investıgatıon of ABCA1 C69T polymorphısm ın patıents wıth type 2 dıabetes mellıtus
INTRODUCTION: Non insulin dependent diabetes mellitus is the most common type of diabetes. Genetic factors, lipid profiles, hypertension are potential risk factors for diabetes mellitus. Adenosine binding cassette transporter proteins 1 (ABCA1) plays a role in cholesterol metabolism, especially high...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Society of Medical Biochemistry and Laboratory Medicine
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062329/ https://www.ncbi.nlm.nih.gov/pubmed/22384526 |
_version_ | 1782321630484103168 |
---|---|
author | Ergen, H. Arzu Zeybek, Ümit Gök, Özlem Karaali, Z. Ermis |
author_facet | Ergen, H. Arzu Zeybek, Ümit Gök, Özlem Karaali, Z. Ermis |
author_sort | Ergen, H. Arzu |
collection | PubMed |
description | INTRODUCTION: Non insulin dependent diabetes mellitus is the most common type of diabetes. Genetic factors, lipid profiles, hypertension are potential risk factors for diabetes mellitus. Adenosine binding cassette transporter proteins 1 (ABCA1) plays a role in cholesterol metabolism, especially high density lipoprotein (HDL-cholesterol). There are multiple mechanisms by which HDL-cholesterol can be atheroprotective, it is clear that the relative activity of ABCA1 plays a major role. We aimed to investigate association of ABCA1 C69T gene polymorphism with lipid levels in Turkish type 2 diabetic patients. MATERIALS AND METHODS: After isolation of DNA by ethanol precipitation we determined ABCA1 gene polymorphism by using polimerase chain reaction - restriction fragment lenght polymorphism (PCR-RFLP) method in 107 type 2 diabetic patients and 50 healthy controls. RESULTS: We have observed that the frequency of TT genotype is significantly higher in healthy controls compared to patients (14% vs. 3%; P = 0.008). Also frequency of T allele was higher in controls than in patients (34% vs. 21%; P = 0.020; OR (95% CI) = 0.52 (0.30–0.88)). There was no association of lipid levels and ABCA1 C69T polymorphism subgroups. CONCLUSION: We have found significantly higher frequency of both T allele and genotype in control group when compared to patients that made us think that T allele may be a protective factor against diabetes mellitus. But, we could not find a relationship between genotypes and lipid concentrations in our two groups. Larger studies will help us to understand the relationship between ABCA1 C69T genotype and lipid parameters in diabetes mellitus. |
format | Online Article Text |
id | pubmed-4062329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Croatian Society of Medical Biochemistry and Laboratory Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-40623292014-06-23 Investıgatıon of ABCA1 C69T polymorphısm ın patıents wıth type 2 dıabetes mellıtus Ergen, H. Arzu Zeybek, Ümit Gök, Özlem Karaali, Z. Ermis Biochem Med (Zagreb) Original Article INTRODUCTION: Non insulin dependent diabetes mellitus is the most common type of diabetes. Genetic factors, lipid profiles, hypertension are potential risk factors for diabetes mellitus. Adenosine binding cassette transporter proteins 1 (ABCA1) plays a role in cholesterol metabolism, especially high density lipoprotein (HDL-cholesterol). There are multiple mechanisms by which HDL-cholesterol can be atheroprotective, it is clear that the relative activity of ABCA1 plays a major role. We aimed to investigate association of ABCA1 C69T gene polymorphism with lipid levels in Turkish type 2 diabetic patients. MATERIALS AND METHODS: After isolation of DNA by ethanol precipitation we determined ABCA1 gene polymorphism by using polimerase chain reaction - restriction fragment lenght polymorphism (PCR-RFLP) method in 107 type 2 diabetic patients and 50 healthy controls. RESULTS: We have observed that the frequency of TT genotype is significantly higher in healthy controls compared to patients (14% vs. 3%; P = 0.008). Also frequency of T allele was higher in controls than in patients (34% vs. 21%; P = 0.020; OR (95% CI) = 0.52 (0.30–0.88)). There was no association of lipid levels and ABCA1 C69T polymorphism subgroups. CONCLUSION: We have found significantly higher frequency of both T allele and genotype in control group when compared to patients that made us think that T allele may be a protective factor against diabetes mellitus. But, we could not find a relationship between genotypes and lipid concentrations in our two groups. Larger studies will help us to understand the relationship between ABCA1 C69T genotype and lipid parameters in diabetes mellitus. Croatian Society of Medical Biochemistry and Laboratory Medicine 2012-02-15 /pmc/articles/PMC4062329/ /pubmed/22384526 Text en © Copyright by Croatian Society of Medical Biochemistry and Laboratory Medicine. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Ergen, H. Arzu Zeybek, Ümit Gök, Özlem Karaali, Z. Ermis Investıgatıon of ABCA1 C69T polymorphısm ın patıents wıth type 2 dıabetes mellıtus |
title | Investıgatıon of ABCA1 C69T polymorphısm ın patıents wıth type 2 dıabetes mellıtus |
title_full | Investıgatıon of ABCA1 C69T polymorphısm ın patıents wıth type 2 dıabetes mellıtus |
title_fullStr | Investıgatıon of ABCA1 C69T polymorphısm ın patıents wıth type 2 dıabetes mellıtus |
title_full_unstemmed | Investıgatıon of ABCA1 C69T polymorphısm ın patıents wıth type 2 dıabetes mellıtus |
title_short | Investıgatıon of ABCA1 C69T polymorphısm ın patıents wıth type 2 dıabetes mellıtus |
title_sort | investıgatıon of abca1 c69t polymorphısm ın patıents wıth type 2 dıabetes mellıtus |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062329/ https://www.ncbi.nlm.nih.gov/pubmed/22384526 |
work_keys_str_mv | AT ergenharzu investıgatıonofabca1c69tpolymorphısmınpatıentswıthtype2dıabetesmellıtus AT zeybekumit investıgatıonofabca1c69tpolymorphısmınpatıentswıthtype2dıabetesmellıtus AT gokozlem investıgatıonofabca1c69tpolymorphısmınpatıentswıthtype2dıabetesmellıtus AT karaalizermis investıgatıonofabca1c69tpolymorphısmınpatıentswıthtype2dıabetesmellıtus |